Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder

J Clin Psychiatry. 2023 Apr 17;84(3):22br14567. doi: 10.4088/JCP.22br14567.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Cues
  • Delayed-Action Preparations / therapeutic use
  • Humans
  • Injections, Intramuscular
  • Naltrexone* / therapeutic use
  • Narcotic Antagonists / therapeutic use
  • Opioid-Related Disorders* / drug therapy

Substances

  • Naltrexone
  • Narcotic Antagonists
  • Delayed-Action Preparations
  • Analgesics, Opioid